Wang D, Zhang C, Zhu P, He S, Chen X. Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.910858][Reference Citation Analysis]
2
Wu Q, Chen Z, Ding Y, Tang Y, Cheng Y. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis. Front Nutr 2022;9:1033129. [DOI: 10.3389/fnut.2022.1033129][Reference Citation Analysis]